S Narouze, HT Benzon, D Provenzano… - Regional Anesthesia & …, 2018 - rapm.bmj.com
Abstract The American Society of Regional Anesthesia and Pain Medicine (ASRA) 2012 survey of meeting attendees showed that existing ASRA anticoagulation guidelines for …
AN Werk, I Cascorbi - Clinical Pharmacology & Therapeutics, 2014 - Wiley Online Library
Cytochrome P450 3A4 (CYP3A4) is involved in the metabolism of more drugs in clinical use than any other foreign compound–metabolizing enzyme in humans. Recently, increasing …
S Narouze, HT Benzon, DA Provenzano… - Regional Anesthesia & …, 2015 - rapm.bmj.com
Interventional spine and pain procedures cover a far broader spectrum than those for regional anesthesia, reflecting diverse targets and goals. When surveyed, interventional …
Palbociclib, ribociclib, and abemaciclib belong to the third generation of cyclin-dependent kinases inhibitors (CDKis), an established therapeutic class for advanced and metastatic …
GX Hu, DP Dai, H Wang, XX Huang, XY Zhou… - …, 2017 - Taylor & Francis
Aim: To systematically investigate the genetic polymorphisms of the CYP3A4 gene in a Han Chinese population. Materials & methods: The promoter and exons of CYP3A4 gene in …
K van der Weide, J van der Weide - Journal of clinical …, 2015 - journals.lww.com
Methods Eight hundred thirty-four adult patients were included in this study, of whom 130 used aripiprazole, 312 used haloperidol, 86 used pimozide, and 396 used risperidone …
CYP3A enzymes participate in the elimination of ticagrelor and the bioactivation of clopidogrel and prasugrel. We studied the effects of functional CYP3A genetic variants …
C Dong, H Zhou, C Shen, LG Yu, Y Ding… - World journal of …, 2015 - ncbi.nlm.nih.gov
Metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are the serious public health problems worldwide. Moreover, it is estimated that MetS patients have about five-fold …
Y Yang, JP Lewis, JS Hulot, SA Scott - Expert opinion on drug …, 2015 - Taylor & Francis
Introduction: Aspirin, clopidogrel, prasugrel and ticagrelor are antiplatelet agents for the prevention of ischemic events in patients with acute coronary syndromes (ACS) …